Timing of treatment initiation in Parkinson's disease: A need for reappraisal?
- 17 February 2006
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 59 (3) , 559-562
- https://doi.org/10.1002/ana.20789
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 yearsMovement Disorders, 2004
- Changes of Dopamine Turnover in the Progression of Parkinson's Disease as Measured by Positron Emission Tomography: Their Relation to Disease-Compensatory MechanismsJournal of Cerebral Blood Flow & Metabolism, 2004
- Time to move beyond nigrostriatal dopamine deficiency in Parkinson's diseaseAnnals of Neurology, 2004
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Impact of sustained deprenyl (selegiline) in levodopa‐treated Parkinson's disease: A randomized placebo‐controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trialAnnals of Neurology, 2002
- The effect of deprenyl and levodopa on the progression of Parkinson's diseaseAnnals of Neurology, 1995
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Striatal and non-striatal neurotransmitter changes in MPTP-parkinsonism in rhesus monkey: The symptomatic versus the asymptomatic conditionNeurochemistry International, 1992
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Compensations after lesions of central dopaminergic neurons: some clinical and basic implicationsTrends in Neurosciences, 1990